» Articles » PMID: 18653246

HIV-1-infected And/or Immune-activated Macrophages Regulate Astrocyte CXCL8 Production Through IL-1beta and TNF-alpha: Involvement of Mitogen-activated Protein Kinases and Protein Kinase R

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2008 Jul 26
PMID 18653246
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Monocyte infiltration is an important pathogenic event in human immunodeficiency virus type one (HIV-1) associated dementia (HAD). CXCL8 (Interleukin 8, IL-8), a CXC chemokine that elicits chemotaxis of neutrophils, has recently been found to recruit monocytes or synergistically enhance CCL2-mediated monocyte migration. In this report, we demonstrate CXCL8 levels in the cerebrospinal fluid of HAD patients are higher than HIV-1 seropositive patients without neurological impairment. The underlying mechanisms regulating CXCL8 production during disease are not completely understood. We investigated the role of HIV-1-infected and immune-competent macrophages, the principal target cell and mediator of neuronal injury in HAD, in regulating astrocyte CXCL8 production. Immune-activated and HIV-1-infected human monocyte-derived-macrophages (MDM) conditioned media (MCM) induced production of CXCL8 by human astrocytes. This CXCL8 production was dependent on MDM IL-1beta and TNF-alpha production following viral and immune activation. CXCL8 production was reduced by inhibitors for mitogen-activated protein kinases (MAPKs), including p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinases (ERK1/2). Moreover, prolonged IL-1beta or TNF-alpha treatment activated double-stranded RNA-activated protein kinase (PKR). Inhibition of PKR prevented elevated CXCL8 production in astrocytes. We conclude that IL-1beta and TNF-alpha, produced from HIV-1-infected and immune-competent macrophages, are critical in astrocyte CXCL8 production. Multiple protein kinases, including p38, JNK, ERK1/2, and PKR, participate in the inflammatory response of astrocytes. These observations will help to identify effective therapeutic strategies to reduce high-levels of CXCL8-mediated CNS inflammation during HAD.

Citing Articles

Neuropathogenesis of HIV and emerging therapeutic targets.

Siddiqui A, He C, Lee G, Figueroa A, Slaughter A, Robinson-Papp J Expert Opin Ther Targets. 2022; 26(7):603-615.

PMID: 35815686 PMC: 9887458. DOI: 10.1080/14728222.2022.2100253.


Exocytosis in Astrocytes.

Mielnicka A, Michaluk P Biomolecules. 2021; 11(9).

PMID: 34572580 PMC: 8471187. DOI: 10.3390/biom11091367.


HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.

Jadhav S, Nema V Mediators Inflamm. 2021; 2021:1267041.

PMID: 34483726 PMC: 8410439. DOI: 10.1155/2021/1267041.


Co-receptor signaling in the pathogenesis of neuroHIV.

Nickoloff-Bybel E, Festa L, Meucci O, Gaskill P Retrovirology. 2021; 18(1):24.

PMID: 34429135 PMC: 8385912. DOI: 10.1186/s12977-021-00569-x.


HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.

Sonti S, Sharma A, Tyagi M Virus Res. 2021; 303:198523.

PMID: 34314771 PMC: 8966056. DOI: 10.1016/j.virusres.2021.198523.


References
1.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

2.
Gendelman H, Orenstein J, Martin M, Ferrua C, Mitra R, Phipps T . Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988; 167(4):1428-41. PMC: 2188914. DOI: 10.1084/jem.167.4.1428. View

3.
Wesselingh S, Power C, Glass J, Tyor W, McArthur J, Farber J . Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol. 1993; 33(6):576-82. DOI: 10.1002/ana.410330604. View

4.
Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K . Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2):153-83. DOI: 10.1210/edrv.22.2.0428. View

5.
Navia B, Jordan B, Price R . The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986; 19(6):517-24. DOI: 10.1002/ana.410190602. View